Editorial: NLRP3 Inflammasome: Regulatory Mechanisms, Role in Health and Disease and Therapeutic Potential.

Chernikov, Oleg V; Moon, Jong-Seok; Chen, Ann; Hua, Kuo-Feng

Chernikov, Oleg V; Moon, Jong-Seok; Chen, Ann; Hua, Kuo-Feng.

Chernikov OV; G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Vladivostok, Russia.
Moon JS; Department of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Cheonan, South Korea.
Chen A; Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Hua KF; Department of Biotechnology and Animal Science, National Ilan University, Ilan, Taiwan.

Front Immunol ; 12: 765199, 2021.

Article in English | MEDLINE | ID: covidwho-1674331

Subject(s)

Inflammasomes/immunology; NLR Family, Pyrin Domain-Containing 3 Protein/immunology; Anti-Inflammatory Agents/therapeutic use; COVID-19/immunology; Humans; COVID-19 Drug Treatment

Keywords

NLRP3 inflammasome; drug target; inflammation; inflammatory disease; therapeutic approach

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammasomes / NLR Family, Pyrin Domain-Containing 3 Protein Limits: Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.765199

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google